Imagine the cell’s nucleus as a bank vault protected by a highly sophisticated security system: the nuclear pore complex (NPC). Only proteins carrying the correct “key” – specialized transport factors – are granted exclusive…

“The closure of this financing round and the successful recruitment of 545 patients in our first clinical study at the University Hospital Basel this year is a huge success”, states Marija Plodinec, CEO of ARTIDIS. “We are…

CV of Prof. Dr. Jean Pieters ORCID 0000-0002-5284-9757 Nationality: Dutch Positions: Since 2002 Professor of Biochemistry, Biozentrum, University of Basel, Switzerland 2000 – 2002 Permanent Member, Basel Institute for…

Many distinguished scientists who collaborated with Erich Nigg in his laboratories in Zurich, Lausanne, Geneva, Munich or Basel, or work in the same field as Erich Nigg, are invited to give a talk at the symposium. The…

Learning ‒ teaching ‒ sparking enthusiasm May 2015 She definitely didn’t want to become a teacher. Yet she is one. For 15 years, Anja Renold has been teaching at the Gymnasium Bäumlihof in Basel. Since 2008, she is also the…

FACS Core Facility Fluorescence Activated Cell Sorting (FACS) is a technology with which mixtures of cells can be analyzed, counted and separated with a special instrument, the flow cytometer. This procedure is already being…

LRBA deficiency is a rare and severe autoimmune disorder that was first described in 2012. This disease is caused by a genetic defect in the LRBA gene and is characterized by an impaired immune response and autoimmunity.…

CV of Prof. Dr. Knut Drescher ORCID 0000-0002-7340-2444 Google Scholar Google Scholar Positions: Since 2021 Associate Professor at the Biozentrum 2015 - 2021 Professor of Biophysics, Philipps-Universität Marburg 2014 - 2021…

Our brain consists of hundreds, if not thousands, of different types of nerve cells that control our brain functions due to their individual characteristics. But how do the different cell types manage to develop their…

SEAL Therapeutics AG: Gene therapy for muscular dystrophy The Biozentrum spin-off develops an innovative gene therapy to treat congenital muscular dystrophy. Cross-section through treated LAMA2 MD muscle with individual…